Ligand validation:6ATT

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6ATT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ATT_NAG_A_703	41%	36%	0.154	0.87	0.78	1.69	-	3	0	0	100%	0.9333
1N8Z_NAG_C_738	48%	54%	0.15	0.893	0.5	1.25	-	2	0	0	100%	0.9333
3BE1_NAG_A_1001	33%	48%	0.222	0.899	0.74	1.24	1	2	3	0	100%	0.9333
5K33_NAG_C_705	30%	75%	0.169	0.833	0.42	0.54	-	-	0	0	100%	0.9333
6BGT_NAG_C_701	21%	53%	0.235	0.848	1.14	0.69	2	1	0	0	100%	0.9333
5O4G_NAG_C_707	11%	89%	0.249	0.76	0.22	0.4	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.